Skyward Specialty Insurance Group, Inc. amended First Amendment with Barclays Bank PLC (effective 2025-12-30).
“On December 30, 2025, the Company entered into the First Amendment (the “Amendment”) to the Credit Agreement, dated November 13, 2025 (the “Existing Credit Agreement”), by and among the Company, the guarantors party thereto, the lenders party thereto and Barclays Bank PLC, as administrative agent.”
SKWDSkyward Specialty Insurance Group, Inc.
Skyward Specialty Insurance Group, Inc. entered into Guaranty Agreement with subsidiary guarantors (effective 2025-12-30).
“In connection with the Credit Agreement, on December 30, 2025, the Company and the subsidiary guarantors party thereto, entered into a Guaranty Agreement (the “Guaranty Agreement”), pursuant to which the Company’s obligations under the Facility are guaranteed by the Company and its existing wholly-owned subsidiaries and subsequently acquired or organized subsidiaries”
SKWDSkyward Specialty Insurance Group, Inc.
Skyward Specialty Insurance Group, Inc. entered into Term Loan Credit Agreement with Barclays Bank PLC, Truist Securities, Inc., Citizens Bank, N.A., Texas Capital Bank valued at $300.0 million (effective 2025-12-30).
“On December 30, 2025, the Company entered into a Term Loan Credit Agreement (the “Facility”) by and among the Company, as Borrower, the lenders from time to time parties thereto (each a “Lender” and collectively, the “Lenders”), Barclays Bank PLC, as Administrative Agent (the “Agent”), and the Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank as joint lead arrangers, joint book runners and co-syndication agents for the Tranche B Term Facility.”
SMXTSolarMax Technology, Inc.
SolarMax Technology, Inc. entered into a supply with Navboot Holdco, LLC valued at approximately $258.1 million (effective 2025-12-31).
“Pursuant to an EPC agreement with Navboot Holdco, LLC, a Delaware limited liability company (“Navboot”), SREP is to develop a BESS facility in Corpus Christi, Texas. The contract is expected to generate revenues of approximately $258.1 million.”
SMXTSolarMax Technology, Inc.
SolarMax Technology, Inc. entered into a supply with Yabucoa BESS LLC valued at approximately $35.9 million (effective 2025-12-31).
“Pursuant to an EPC agreement with Yabucoa BESS LLC, a Texas limited liability company (“Yabucoa”), SREP is to develop a BESS facility in Humacao Municipality, Puerto Rico. The contract is expected to generate revenues of approximately $35.9 million.”
SMXTSolarMax Technology, Inc.
SolarMax Technology, Inc. entered into a supply with Naguabo BESS LLC valued at approximately $122.3 million (effective 2025-12-31).
“Pursuant to an EPC agreement with Naguabo BESS LLC, a Texas limited liability company (“Naguabo”), SREP is to develop a BESS facility in Ceiba Municipality, Puerto Rico. The contract is expected to generate revenues of approximately $122.3 million.”
HRGNHarvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. entered into Purchase Agreement with certain investors valued at aggregate of 411,765 shares of common stock for the aggregate purchase price of approximately $0.7 m (effective 2025-12-30).
“Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement”), each effective as of December 30, 2025, with certain investors (the “Investors”) pursuant to which the Investors agreed to purchase in a private placement an aggregate of 411,765 shares of common stock for the aggregate purchase price of approximately $0.7 million and a purchase price per share of $1.70 (the “Private Placement”).”
BAFNBayFirst Financial Corp.
BayFirst Financial Corp. amended Amendment with the holders of the Company’s $6.0 million of 4.5% Fixed to Floating Subordinated Notes Due June 30, 2031 valued at $6.0 million (effective 2025-12-26).
“On December 29, 2025, BayFirst Financial Corp. (the “Company”) and the holders of the Company’s $6.0 million of 4.5% Fixed to Floating Subordinated Notes Due June 30, 2031 (the “Notes”) entered into an Amendment to the Notes (the “Amendment”), effective as of December 26, 2025.”
CYCNCyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. entered into Collaboration and Option Agreement with Medsteer, SAS valued at up to $3.7 million (effective 2026-01-03).
“On January 3, 2026, Cyclerion Therapeutics, Inc. (the “Company”) and the Medsteer, SAS (“Medsteer”) entered into a Collaboration and Option Agreement (the “Collaboration Agreement”) pursuant to which Medsteer granted to the Company (i) a non-exclusive, worldwide, royalty-free, sublicensable license of certain of Medsteer’s technology, software and intellectual property to develop an anesthetic delivery system with Medsteer”
TWTradeweb Markets Inc.
Tradeweb Markets Inc. amended Amendments to Master Data Agreement with Refinitiv US LLC and Refinitiv US Organization LLC (LSEG Parties) valued at fixed license fees or fees based on percentage of revenue (effective 2025-11-01).
“On December 31, 2025, Tradeweb Markets LLC (“Tradeweb Markets”), a wholly owned subsidiary of Tradeweb Markets Inc. (the “Company”), entered into a series of amendments effective as of November 1, 2025 (the “Amendments”) with Refinitiv US LLC and Refinitiv US Organization LLC (together, the “LSEG Parties”) to the master data license agreement, effective as of November 1, 2023, among Tradeweb Markets and the LSEG Parties (the “Master Data Agreement”).”
TILInstil Bio, Inc.
Instil Bio, Inc. terminated License and Collaboration Agreement with ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (effective 2026-01-05).
“Axion Bio, Inc. (“Axion”), a wholly-owned subsidiary of Instil Bio, Inc., and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (“ImmuneOnco”) entered into an agreement terminating, effective January 5, 2026, the License and Collaboration Agreement dated August 1, 2024 between ImmuneOnco and Axion”
Blue Owl Credit Income Corp.
Blue Owl Credit Income Corp. entered into Secured Credit Facility with Société Générale, as administrative agent and swingline lender, State Street Bank and Trust Company, as collateral agent, collateral administrator, custodian and document custodian, and the lenders party thereto valued at $750 million (effective 2025-12-31).
“On December 31, 2025 (the “Closing Date”), Core Income Funding X LLC (“Core Income Funding X”), a Delaware limited liability company and a newly formed subsidiary of Blue Owl Credit Income Corp., a Maryland corporation (the “Company” or “us”) entered into a Revolving Credit and Security Agreement (the “Secured Credit Facility”), with Core Income Funding X, as borrower, Société Générale, as administrative agent and swingline lender, State Street Bank and Trust Company, as collateral agent, collateral administrator, custodian and document custodian, and the lenders party thereto.”
ESLAEstrella Immunopharma, Inc.
Estrella Immunopharma, Inc. entered into Registration Rights Agreement with the Investor (effective 2026-01-05).
“In connection with the Private Placement, the Company and the Investor entered into a registration rights agreement, dated January 5, 2026 (the “Registration Rights Agreement”), pursuant to which the Company agreed to file a registration statement (the “Resale Registration Statement”), providing for the resale of the shares of Common Stock issued and issuable upon exercise of the PIPE Common Warrants within thirty (30) days of the closing of the Offering, to have such registration statement declared effective within sixty (60) days of the closing date (or ninety (90) days of the closing date if the SEC conducts a full review of a Resale Registration Statement), and to maintain the effectiveness of such registration statement until the earlier of (i) the date on which all such securities have been sold thereunder or pursuant to Rule 144, or (ii) the date on which such securities are eligible for resale without the need for registration under the Securities Act.”
ESLAEstrella Immunopharma, Inc.
Estrella Immunopharma, Inc. entered into Placement Agent Agreement with Aegis Capital Corp. (effective 2026-01-05).
“In connection with the Offerings, the Company also entered into a placement agent agreement, dated January 5, 2026 (the “Placement Agent Agreement”), with Aegis Capital Corp. (the “Placement Agent”), pursuant to which the Company paid the Placement Agent a cash fee equal to 6.0% of the aggregate gross proceeds of the Offerings and reimbursed the Placement Agent for certain expenses and legal fees.”
ESLAEstrella Immunopharma, Inc.
Estrella Immunopharma, Inc. entered into Securities Purchase Agreement with a healthcare-focused institutional investor valued at approximately $8.0 million (effective 2026-01-05).
“On January 5, 2026, Estrella Immunopharma, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a healthcare-focused institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell to the Investor (a) in a registered direct offering (the “Registered Direct Offering”) (i) 4,063,290 shares (the “Shares”) of common stock, par value $0.0001 per share (“Common Stock”), of the Company, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 1,000,000 shares of Common Stock for $0.00001 per share; and (b) in a concurrent private placement (the “Private Placement,” and together with the Registered Direct Offering, the “Offerings”), common stock purchase warrants (the “PIPE Common Warrants”), exercisable for up to an aggregate of 7,594,935 shares of Common Stock for $1.39 per share, subject to customary anti-dilution adjustments for stock splits, reclassifications and recapitalizations of the Co”
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. entered into CVR Agreement with Rights Agent (effective 2026-01-06).
“on January 6, 2026, the Parent and the Rights Agent entered into the CVR Agreement governing the terms of the CVRs issued pursuant to the Offer and the Merger”
ASBPAspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. entered into Exchange Agreements with certain holders of the Company’s debt valued at approximately $1.75 million (effective 2026-01-01).
“On January 1, 2026, the Company entered into Exchange Agreements (the “Exchange Agreements”) with certain holders of the Company’s debt (the “Holders”) to exchange approximately $1.75 million in debt for shares (the “Exchange Shares’) of the Company’s common stock (the “Exchange”).”
OneStream, Inc.
OneStream, Inc. entered into Agreement and Plan of Merger with Onward AcquireCo, Inc., Onward Merger Sub 2, LLC, Onward Merger Sub, Inc. valued at $24.00 (effective 2026-01-06).
“On January 6, 2026, OneStream, Inc. (“OneStream”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with OneStream Software LLC (“OneStream LLC” and, together with OneStream, the “OneStream Parties”), Onward AcquireCo, Inc. (“Parent”), Onward Merger Sub 2, LLC (“Merger Sub I”) and Onward Merger Sub, Inc. (“Merger Sub II” and, together with Merger Sub I, the “Merger Subs”).”
MBLYMobileye Global Inc.
Mobileye Global Inc. entered into Share Purchase Agreement with Mentee Robotics Ltd. valued at $900,000,000 (effective 2026-01-05).
“On January 5, 2026, Mobileye Global Inc. (the “Corporation”), a Delaware corporation, and Mobileye Vision Technologies Ltd. (“MEIL”), a company organized under the laws of the State of Israel and a subsidiary of the Corporation, entered into a share purchase agreement (the “Share Purchase Agreement”) to acquire 100% of the issued and outstanding stock of Mentee Robotics Ltd.”
RENXRenX Enterprises Corp.
RenX Enterprises Corp. entered into Notes with Commercial Credit Group valued at approximately $2.54 million (effective 2025-12-30).
“Effective December 30, 2025, Resource Group LLC (“Resource Group”), a wholly owned subsidiary of RenX Enterprises Corp. (the “Company”), entered into a Negotiable Promissory Note and Security Agreement in the principal amount of $1,507,658 (the “First Note”) and Negotiable Promissory Note and Security Agreement in the principal amount of $1,047,528 (the “Second Note”; and together with the First Note, the “Notes”) with Commercial Credit Group (the “Lender”) to finance the purchase of a Komptech Crambo shredder and a Diamond Z horizontal grinder for approximately $2.54 million with a 30% down payment of approximately $700,000 that had previously been deployed under a rental arrangement.”
MGTEMarblegate Capital Corp
Marblegate Capital Corp entered into Loan and Security Agreement with Auxilior Capital Partners, Inc. valued at approximately $17.2 million (effective 2025-12-31).
“On December 31, 2025, certain wholly owned subsidiaries (the “ Mini-Fleets ”) of DePalma Acquisition II LLC (“ DPA 2 ”) entered into a Loan and Security Agreement (the “ Vehicle Loan Agreement ”) with Auxilior Capital Partners, Inc. (“ Auxilior ”), which provides for loans in the aggregate amount of approximately $17.2 million to finance certain fleets of taxicab vehicles.”
MGTEMarblegate Capital Corp
Marblegate Capital Corp entered into Membership Interest Purchase Agreement with TML Holding, Inc. and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Frankfurt Am Main, New York Branch valued at approximately $15.8 million (effective 2025-12-30).
“On December 30, 2025, MCC also entered into a Membership Interest Purchase Agreement (the “ MIPA ”) with TML Holding, Inc. (the “ Seller ”) and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Frankfurt Am Main, New York Branch, pursuant to which MCC purchased 100% of the membership interests in TML IV LLC (“ TML IV ”) for a purchase price of approximately $15.8 million.”
MGTEMarblegate Capital Corp
Marblegate Capital Corp entered into Receivables Loan and Security Agreement with the lenders from time to time party thereto, and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main, New York Branch, as agent valued at $120,000,000 (effective 2025-12-30).
“On December 30, 2025, subsidiaries of Marblegate Capital Corporation (“ MCC ”) entered into a Receivables Loan and Security Agreement (the “ Loan Agreement ”) by and among DePalma Financing SPV I LLC (the “ Borrower ”), DePalma Acquisition I LLC (“ DPA 1 ”), individually as servicer and as seller, the lenders from time to time party thereto (the “Lenders”), and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main, New York Branch, as agent (the “ Agent ”).”
MURMURPHY OIL CORP
MURPHY OIL CORP amended Second Amendment with JP Morgan Chase Bank, N.A. as administrative agent, and each of the lenders party thereto (effective 2026-01-02).
“On January 2, 2026, Murphy Oil Corporation (the “Company”) entered into an amendment (the “Second Amendment”) to its credit agreement dated October 7, 2024 (as previously amended, the “Credit Agreement”) with, among others, the Company, Murphy Exploration & Production Company – International and Murphy Oil Company Ltd. as borrowers, Murphy Exploration & Production Company and Murphy Exploration & Production Company – USA, as guarantors, JP Morgan Chase Bank, N.A. as administrative agent, and each of the lenders party thereto.”
STAASTAAR SURGICAL CO
STAAR SURGICAL CO terminated Agreement and Plan of Merger with Alcon Research, LLC (effective 2026-01-06).
“As previously disclosed, on August 4, 2025, STAAR Surgical Company (the “Company”) entered into an Agreement and Plan of Merger, dated as of August 4, 2025 (as amended, the “Merger Agreement”), by and among the Company, Alcon Research, LLC (“Alcon”) and Rascasse Merger Sub, Inc.”
GERNGERON CORP
GERON CORP amended First Amendment to Loan Agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership valued at Extended outside date for Tranche B and Tranche C loan availability from December 31, 2025 to July 3 (effective 2026-01-05).
“On January 5, 2026, Geron Corporation ("we" or the "Company") entered into that certain first amendment to loan agreement (the "First Amendment Agreement") with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a "Lender"), which are investment funds managed by Pharmakon Advisors, LP, and BioPharma Credit PLC, as collateral agent (the "Agent"), which amends the terms of that certain Loan Agreement, dated as of November 1, 2024 (the "Loan Agreement", and as amended by the First Amendment Agreement, the "Amended Loan Agreement), by and among the Company, the Lenders and the Agent.”
OTLCOncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc. amended ICA with Jefferson Capital Ventures, LLC (effective 2025-12-31).
“On December 31, 2025, Oncotelic Therapeutics, Inc. (the “Company” or “Our”) entered into an amendment to an independent contractor agreements (“ICA”) with Jefferson Capital Ventures, LLC (“Jefferson”) dated August 6, 2025, for modifying the threshold of the first milestone contained within the ICA.”
LFMDLifeMD, Inc.
LifeMD, Inc. entered into Credit Agreement with Citizens Bank, N.A. valued at $30 million (effective 2026-01-02).
“On January 2, 2026, LifeMD, Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with Citizens Bank, N.A. (the “Lender”), which provides for a senior secured revolving credit facility in an aggregate outstanding amount not exceeding $30 million (the “Credit Facility”)”
TRNTRINITY INDUSTRIES INC
TRINITY INDUSTRIES INC entered into Sale and Exchange Agreement with Napier Park Railcar Lease Fund LLC valued at approximately $190 million (effective 2025-12-30).
“On December 30, 2025, Trinity Industries Leasing Company (“TILC”), a wholly-owned direct subsidiary of Trinity Industries, Inc. (“Trinity” or the “Company”), entered into a Sale and Exchange Agreement (the “Exchange Agreement”) with Napier Park Railcar Lease Fund LLC (“Napier Park”).”
OCFCOCEANFIRST FINANCIAL CORP
OCEANFIRST FINANCIAL CORP entered into Agreement and Plan of Merger with Flushing Financial Corporation (effective 2025-12-29).
“On December 29, 2025, OceanFirst Financial Corp., a Delaware corporation (" OceanFirst "), Flushing Financial Corporation, a Delaware corporation (" Flushing "), and Apollo Merger Sub Corp., a Delaware corporation and wholly-owned subsidiary of OceanFirst (" Merger Sub "), entered into an Agreement and Plan of Merger (the " Merger Agreement ").”
NORDNordicus Partners Corp
Nordicus Partners Corp entered into a equity purchase with ten private investors valued at $2.75 per share.
“In December 2025, we issued to ten private investors a total of 131,000 restricted shares of our common stock, par value $0.01 per share. The price per share was $2.75.”
TACTTRANSACT TECHNOLOGIES INC
TRANSACT TECHNOLOGIES INC terminated License Agreements with Avery Dennison Corporation and StreemSoft LLC (effective 2025-12-30).
“On December 30, 2025, TransAct Technologies Incorporated (the “Company”) agreed with Avery Dennison Corporation (“AD”) and StreemSoft LLC (formerly, ZippyYum LLC) (“StreemSoft”) to terminate (i) that certain Master License Agreement, dated February 22, 2019, as amended (the “MLA”), (ii) that certain Master Development and License Agreement, dated July 20, 2018 (the “MDLA”), entered into by and between the Company and StreemSoft, (iii) the related Subcontract Agreement, dated March 18, 2021, between StreemSoft and AD, and (iv) the Agreement to Accommodate Sale by ZippyYum to AD, dated March 16, 2021 (collectively, the “License Agreements”).”
SNDASONIDA SENIOR LIVING, INC.
SONIDA SENIOR LIVING, INC. entered into Credit Agreement with BMO Bank, N.A., as administrative agent (effective 2025-12-29).
“On December 29, 2025, Sonida Senior Living, Inc., a Delaware corporation (the “ Company ”), entered into an amended and restated credit agreement, dated as of December 29, 2025 (the “ Credit Agreement ”), among the Company, as borrower, the guarantors from time to time party thereto, the lenders from time to time party thereto (the “ Lenders ”), and BMO Bank, N.A., as administrative agent.”
HUNTSMAN INTERNATIONAL LLC
HUNTSMAN INTERNATIONAL LLC amended Master Amendment No. 13 to the U.S. Receivables Loan Agreement and Transaction Documents with The Toronto-Dominion Bank valued at $180 million (effective 2025-12-29).
“On December 29, 2025, Huntsman International LLC (“Huntsman International”) entered into Master Amendment No. 13 to the U.S. Receivables Loan Agreement and Transaction Documents (the “U.S. A/R Program Amendment 13”), among Huntsman International, Huntsman Receivables Finance II LLC, VANTICO GROUP S.à r.1., as master servicer, The Toronto-Dominion Bank (“TD”), as successor administrative agent and successor collateral agent, and the other financial institutions party thereto.”
VRMEVerifyMe, Inc.
VerifyMe, Inc. entered into LOI with Open World Ltd. (effective 2026-01-02).
“On January 2, 2026, VerifyMe, Inc. (the “Company”) entered into a letter agreement (the “LOI”) with Open World Ltd., a Cayman Islands exempted company (“Open World”), regarding a proposed merger transaction.”
BBWBUILD-A-BEAR WORKSHOP INC
BUILD-A-BEAR WORKSHOP INC entered into Third Amendment to Revolving Credit and Security Agreement with PNC Bank, National Association valued at Borrowing base increased from $25.0 million to $40.0 million, with accordion feature up to $50.0 mil (effective 2025-12-31).
“On December 31, 2025, Build-A-Bear Workshop, Inc. (the “Company”), as borrowing agent; Build-A-Bear Retail Management, Inc., together with the Company, as borrowers (collectively, the “Borrowers”); and Build-A-Bear Workshop Franchise Holdings, Inc., Build-A-Bear Entertainment, LLC, Build-A-Bear Card Services, LLC and Build-A-Bear Workshop Canada, Ltd. (collectively, the “Guarantors”); entered into a Third Amendment to Revolving Credit and Security Agreement (the “Third Amendment”) with the lenders party thereto (the “Lenders”) and PNC Bank, National Association, as agent for Lenders (in such capacity, “Agent”).”
FCCNSPECTRAL CAPITAL Corp
SPECTRAL CAPITAL Corp entered into Definitive Stock Purchase Agreement with Telvantis, Inc. (effective 2025-12-29).
“On December 29, 2025, Spectral Capital Corporation, a Nevada corporation (the “Company”), entered into a Definitive Stock Purchase Agreement (the “Purchase Agreement”) with Telvantis, Inc., formerly Raadr, Inc., a Nevada corporation (“Seller”), pursuant to which the Company agreed to acquire 100% of the issued and outstanding shares of Telvantis Voice Services, Inc., a Florida corporation (the “Acquired Company”).”
TX Rail Products, Inc.
TX Rail Products, Inc. entered into a equity purchase valued at $1,800,000 (effective 2025-12-23).
“In December 2025, TX Rail Products, Inc (“the company”) entered into a private placement transaction whereby it will sell to a single institutional investor six million shares (6,000,000) of the Company’s no par value Common Stock at a purchase price of $0.30 per share, for a total purchase price of $1,800,000.”
WFN CREDIT CO LLC
WFN CREDIT CO LLC amended Fifth Addendum with Comenity Servicing LLC (effective 2026-01-01).
“On January 1, 2026, Comenity Bank (“Bank”) and Comenity Servicing LLC (“CSERV”) entered into the Fifth Addendum (“Fifth Addendum”) to that certain Sixth Amended and Restated Service Agreement, dated as of January 1, 2025, pursuant to which CSERV provides certain services to Bank”
QXOQXO, Inc.
QXO, Inc. entered into Investment Agreement with AP Quince Holdings, L.P., a fund managed by affiliates of Apollo Global Management, Inc. and the other investors party thereto valued at $1,145 million (effective 2026-01-05).
“On January 5, 2026, QXO, Inc. (“QXO” or the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with AP Quince Holdings, L.P., a fund managed by affiliates of Apollo Global Management, Inc. (together with its affiliates, the “Apollo Investor”) and the other investors party thereto (and, together with the Apollo Investor, the “Convertible Preferred Investors”).”
ZDPYZoned Properties, Inc.
Zoned Properties, Inc. entered into Consent Agreement with Broken Arrow Herbal Center, Inc., AC Management Group, LLC, A&R Consultants, LLC and Elevate Holdings, Group, LLC (effective 2025-12-30).
“on December 30, 2025, the Company, through Chino Valley Properties, LLC, entered into a Consent of Landlord and Agreement Regarding Lease (the “Consent Agreement”) with Broken Arrow Herbal Center, Inc., AC Management Group, LLC (the existing guarantor), A&R Consultants, LLC (the new guarantor) and Elevate Holdings, Group, LLC.”
ZDPYZoned Properties, Inc.
Zoned Properties, Inc. amended A&R Leases with Broken Arrow Herbal Center, Inc. and CJK, Inc. (effective 2025-12-31).
“On December 31, 2025, Zoned Properties, Inc. (the “Company”), through its indirect wholly owned subsidiaries Chino Valley Properties, LLC, Green Valley Group, LLC and Kingman Property Group, LLC (collectively, the “Landlords”), entered into Amended and Restated Absolute Net Lease Agreements (the “A&R Leases”) with the respective tenant entities Broken Arrow Herbal Center, Inc. (Chino Valley and Green Valley) and CJK, Inc. (Kingman) (each, a “Tenant”), each with an effective date of January 1, 2026.”
CLPTClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. amended Consent to Note Purchase Agreement with CALW SA LLC (as Purchaser Agent) and TPC Investments III LP (affiliate of Oberland Capital Management LLC) valued at Consent to allow internal reorganization of Swedish subsidiary and qualify IRRAS AB as an Immaterial (effective 2025-12-29).
“On December 29, 2025, the Company entered into a Consent (the “Consent”) with Purchaser Agent and the 2025 Investor providing for the Company to undertake the following actions no later than January 15, 2026: (i) an internal reorganization involving the Company’s Swedish subsidiary, IRRAS AB, including the transfer of all equity interests of IRRAS USA, Inc. owned by IRRAS AB to the Company or its direct, wholly owned U.S. subsidiary in exchange for a subordinated intercompany note, and (ii) other further actions so as to allow IRRAS AB to qualify as an “Immaterial Foreign Subsidiary” under the terms of the Note Purchase Agreement.”
DRTTFDIRTT ENVIRONMENTAL SOLUTIONS LTD
DIRTT ENVIRONMENTAL SOLUTIONS LTD terminated Lease with PDM US, LLC valued at US$1 million (effective 2025-12-30).
“Effective December 30, 2025, the Lease was terminated pursuant to the Agreement, and the Tenant was relieved from any future rent obligations under the Lease in exchange for an early termination fee of US$1 million paid by the Tenant to PDM.”
HNOIHNO International, Inc.
HNO International, Inc. amended 5 th Extension with HNO Green Fuels, Inc. (effective 2025-12-29).
“December 29, 2025, the Company entered into an Extension to Promissory Note (the "5 th Extension") with HNOGF, pursuant to the terms set forth in the 5 th Extension.”
HNOIHNO International, Inc.
HNO International, Inc. amended 4 th Extension with HNO Green Fuels, Inc. (effective 2025-12-29).
“On December 29, 2025, the Company entered into an Extension to Promissory Note (the "4 th Extension") with HNOGF, pursuant to the terms set forth in the 4 th Extension.”
HNOIHNO International, Inc.
HNO International, Inc. amended 3 rd Extension with HNO Green Fuels, Inc. (effective 2025-12-29).
“On December 29, 2025, the Company entered into an Extension to Promissory Note (the "3 rd Extension") with HNOGF, pursuant to the terms set forth in the 3 rd Extension.”
HNOIHNO International, Inc.
HNO International, Inc. amended 2 nd Extension with HNO Green Fuels, Inc. (effective 2025-12-29).
“On December 29, 2025, the Company entered into an Extension to Promissory Note (the "2 nd Extension") with HNOGF, pursuant to the terms set forth in the 2 nd Extension.”
HNOIHNO International, Inc.
HNO International, Inc. amended 1 st Extension with HNO Green Fuels, Inc. (effective 2025-12-29).
“On December 29, 2025, HNO International, Inc., a Nevada corporation (the "Company"), entered into an Extension to Promissory Note (the "1 st Extension") with HNO Green Fuels, Inc., a Nevada corporation ("HNOGF"), pursuant to the terms set forth in the 1 st Extension.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.